Investigating The Potential Effect Of A Novel Immune Regulator (JET) In Preventing Graft Versus Host Disease
Funder
National Health and Medical Research Council
Funding Amount
$82,895.00
Summary
Graft Versus Host Disease (GVHD) is the primary complication of bone marrow transplants, in which the donor T-cells react with the recipient’s cells causing organ damage. Current treatments are not specific and cause further health problems. This research aims to test the therapeutic potential of a newly discovered molecule (JET) in treating and preventing GVHD. If successful, JET has the potential for treating other conditions such as rheumatoid arthritis, multiple sclerosis and miscarriages.